GENE ONLINE|News &
Opinion
Blog

2021-02-01| Technology

TALEN Proves to be a Better Gene Editor than CRISPR in Densely Packed DNA

by Sahana Shankar
Share To
Apart from CRISPR, there have been many genome editing technologies that have been tried and tested. TALENs (Transcription activator-like effector nuclease) are widely used to scan, target, and edit DNA. They are similar to Cas9 in their recognition of signature DNA sequence but differ in their target-binding mode.

TALENs can be customized to recognize an array of 33-34 amino acid sequences, which enables DNA-binding to the target. A new report in Nature Communications demonstrated that TALEN could outperform CRISPR in certain regions of DNA.

GO Prime with only $1.49 now

LATEST
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top